Biondo Investment Advisors buys $20,785,943 stake in Intuitive Surgical (ISRG)

Intuitive Surgical (ISRG) : Biondo Investment Advisors scooped up 1,285 additional shares in Intuitive Surgical during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 9, 2016. The investment management firm now holds a total of 33,056 shares of Intuitive Surgical which is valued at $20,785,943.Intuitive Surgical makes up approximately 7.92% of Biondo Investment Advisors’s portfolio.

Other Hedge Funds, Including , Capital Fund Management S.a. sold out all of its stake in ISRG during the most recent quarter. The investment firm sold 7,535 shares of ISRG which is valued $4,663,864. Strategy Asset Managers added ISRG to its portfolio by purchasing 4,480 company shares during the most recent quarter which is valued at $2,806,093. Intuitive Surgical makes up approx 0.63% of Strategy Asset Managers’s portfolio. Rand Wealth sold out all of its stake in ISRG during the most recent quarter. The investment firm sold 420 shares of ISRG which is valued $263,071.

Intuitive Surgical closed down -4.49 points or -0.71% at $628.81 with 2,26,588 shares getting traded on Friday. Post opening the session at $634.02, the shares hit an intraday low of $626.65 and an intraday high of $637.49 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Intuitive Surgical reported $4.42 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $4.33. The company had revenue of $594.50 million for the quarter, compared to analysts expectations of $591.18 million. The company’s revenue was up 11.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.57 EPS.

Many Wall Street Analysts have commented on Intuitive Surgical. Company shares were Reiterated by RBC Capital Mkts on Apr 20, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 640 from a previous price target of $610 .Company shares were Reiterated by Stifel on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 700 from a previous price target of $640 .Company shares were Reiterated by Piper Jaffray on Apr 20, 2016 to “Neutral”, Firm has raised the Price Target to $ 610 from a previous price target of $550 .

Intuitive Surgical Inc. designs manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control range of motion tissue manipulation and three-dimensional (3-D) high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System the da Vinci Si Surgical System the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery gynecologic surgery general surgery cardiothoracic surgery and head and neck surgery.

Leave a Reply

Intuitive Surgical - Is it time to Sell?

Top Brokerage Firms are advising their investors on Intuitive Surgical. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.